bioAffinity Technologies, Inc.(BIAF)

Medical - Diagnostics & Research · San Antonio, TX

$6.56+0.37 (+5.98%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

bioAffinity Technologies (BIAF) OCF Yield: History & Chart | TGMCharts

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T13:30:45.210Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:30:45.210Z.

Quote observation: 2026-10-06T13:30:00.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -11,468,205
Quote market capitalization: 2,747,794

FMP input reference: b8a0cb47064437e8b9c77c3ec53eeb060705b9d611480c07f1c1fa4a72564033

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BIAF Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

BIAF Competitors' Operating Cash Flow Yield

BIAF

bioAffinity Technologies, Inc.

Current

Market Cap

$2.75M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ISPC

iSpecimen Inc.

vs BIAF

Market Cap

$2.62M

Operating Cash Flow Yield

N/A

TTM Avg

0.03%

3Y Avg

0.03%

5Y Avg

0.03%

FBLG

FibroBiologics, Inc. Common Stock

vs BIAF

Market Cap

$2.52M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ITOC

iTonic Holdings Ltd.

vs BIAF

Market Cap

$2.38M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELZ

Creative Medical Technology Holdings, Inc.

vs BIAF

Market Cap

$2.32M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOVX

GeoVax Labs, Inc.

vs BIAF

Market Cap

$2.22M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BRTX

BioRestorative Therapies, Inc.

vs BIAF

Market Cap

$3.04M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JAGX

Jaguar Health, Inc.

vs BIAF

Market Cap

$2.93M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADGM

Adagio Medical Holdings, Inc.

vs BIAF

Market Cap

$3.07M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AMIX

Autonomix Medical, Inc.

vs BIAF

Market Cap

$1.92M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
bioAffinity Technologies, Inc. (BIAF)	$2.75M	N/A	N/A	N/A	N/A
iSpecimen Inc. (ISPC)vs ›	$2.62M	N/A	0.03%	0.03%	0.03%
FibroBiologics, Inc. Common Stock (FBLG)vs ›	$2.52M	N/A	N/A	N/A	N/A
iTonic Holdings Ltd. (ITOC)vs ›	$2.38M	N/A	N/A	N/A	N/A
Creative Medical Technology Holdings, Inc. (CELZ)vs ›	$2.32M	N/A	N/A	N/A	N/A
GeoVax Labs, Inc. (GOVX)vs ›	$2.22M	N/A	N/A	N/A	N/A
BioRestorative Therapies, Inc. (BRTX)vs ›	$3.04M	N/A	N/A	N/A	N/A
Jaguar Health, Inc. (JAGX)vs ›	$2.93M	N/A	N/A	N/A	N/A
Adagio Medical Holdings, Inc. (ADGM)vs ›	$3.07M	N/A	N/A	N/A	N/A
Autonomix Medical, Inc. (AMIX)vs ›	$1.92M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

BIAF Operating Cash Flow Yield Metrics

BIAF Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics